These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 1384258)

  • 1. Acute bilateral parotitis during chemotherapy for acute lymphoblastic leukemia.
    Humphries JE; Lee JT
    Acta Haematol; 1992; 88(1):55-6. PubMed ID: 1384258
    [No Abstract]   [Full Text] [Related]  

  • 2. L-asparaginase-induced Parotitis in an Elderly Patient with Acute Lymphoblastic Leukemia.
    Saburi M; Ogata M; Soga Y; Itani K; Kohno K; Nakayama T
    Intern Med; 2020 Jul; 59(14):1745-1748. PubMed ID: 32296003
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Asparaginase-induced acute parotitis: an uncommon and self-limiting complication.
    Chan GC; Chiang AK; Ha SY; Lau YL; Ong JB; Lee AC
    Med Pediatr Oncol; 2002 Jul; 39(1):73-4. PubMed ID: 12116090
    [No Abstract]   [Full Text] [Related]  

  • 4. L-asparaginase induced acute parotitis during intensification therapy of acute lymphoblastic leukemia.
    Kathwate J; Mundada S; Patil P
    Indian J Cancer; 2014; 51(4):537. PubMed ID: 26842187
    [No Abstract]   [Full Text] [Related]  

  • 5. Recurrent bilateral parotitis in acute myeloid leukemia.
    Shpilberg O; Ra'anani P; Ben-Bassat I; Ramot B
    Acta Haematol; 1991; 86(1):56. PubMed ID: 1950368
    [No Abstract]   [Full Text] [Related]  

  • 6. [The programmed therapy of acute lymphoblastic leukemia in adults].
    Isaev VG; Savchenko VG; Kucher RA; Abakumov EM; Parovichnikova EN
    Ter Arkh; 1992; 64(8):82-7. PubMed ID: 1440405
    [No Abstract]   [Full Text] [Related]  

  • 7. Neutrophilic eccrine hidradenitis.
    Thorisdottir K; Tomecki KJ; Bergfeld WF; Andresen SW
    J Am Acad Dermatol; 1993 May; 28(5 Pt 1):775-7. PubMed ID: 8496425
    [No Abstract]   [Full Text] [Related]  

  • 8. Liposomal daunorubicin, fludarabine, and cytarabine (FLAD) as bridge therapy to stem cell transplant in relapsed and refractory acute leukemia.
    De Astis E; Clavio M; Raiola AM; Ghiso A; Guolo F; Minetto P; Galaverna F; Miglino M; Di Grazia C; Ballerini F; Marani C; Pastori G; Mitscheunig L; Cruciani F; Lovera D; Varaldo R; Ghiggi C; Lemoli RM; Bacigalupo A; Gobbi M
    Ann Hematol; 2014 Dec; 93(12):2011-8. PubMed ID: 24989345
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cytarabine induced noncardiogenic pulmonary edema in a case of acute lymphoblastic leukemia.
    Yegin ZA; Aki S; Sucak G; Yagci M
    Int J Lab Hematol; 2007 Dec; 29(6):482-3. PubMed ID: 17988309
    [No Abstract]   [Full Text] [Related]  

  • 10. Acute parotitis during induction therapy including L-asparaginase in acute lymphoblastic leukemia.
    Sica S; Pagano L; Salutari P; Di Mario A; Rutella S; Leone G
    Ann Hematol; 1994 Feb; 68(2):91-2. PubMed ID: 8148421
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Idarubicin in acute leukemias: experience of the Italian Cooperative Group GIMEMA.
    Petti MC; Mandelli F
    Semin Oncol; 1989 Feb; 16(1 Suppl 2):10-5. PubMed ID: 2928805
    [No Abstract]   [Full Text] [Related]  

  • 12. [Effectiveness of empirical antibiotic therapy in the control of infections in patients with acute leukemia during severe neutropenia].
    Hansz J; Woźny T; Bajko G; Drozdowska D
    Pol Arch Med Wewn; 1992 Jun; 87(6):379-85. PubMed ID: 1408996
    [TBL] [Abstract][Full Text] [Related]  

  • 13. High-dose cytarabine-based therapy in adults with acute lymphoblastic leukemia.
    Feldman EJ
    Leuk Res; 2000 Mar; 24(3):189-91. PubMed ID: 10739000
    [No Abstract]   [Full Text] [Related]  

  • 14. Herpes simplex virus reactivation and disease during treatment for childhood acute lymphoblastic leukemia.
    Lauten M; Güttel C; Härtel C; Erdlenbruch B
    Klin Padiatr; 2014 May; 226(3):188-9. PubMed ID: 24158893
    [No Abstract]   [Full Text] [Related]  

  • 15. Increasing aclarubicin dose in low-dose cytarabine and aclarubicin in combination with granulocyte colony-stimulating factor (CAG regimen) is efficacious as salvage chemotherapy for relapsed/refractory mixed-phenotype acute leukemia.
    Liu L; Qu Q; Jiao W; Zhang Y; Li X; Ding C; Wu D
    Leuk Res; 2015 Aug; 39(8):805-11. PubMed ID: 26021434
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prospective study of hemostatic alterations in children with acute lymphoblastic leukemia.
    Giordano P; Molinari AC; Del Vecchio GC; Saracco P; Russo G; Altomare M; Perutelli P; Crescenzio N; Santoro N; Marchetti M; De Mattia D; Falanga A
    Am J Hematol; 2010 May; 85(5):325-30. PubMed ID: 20425794
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Molecular genetic detection of minimal residual disease (MRD) in children with acute lymphoblastic leukemia].
    Koehler R; Bartram CR
    Klin Padiatr; 2013 May; 225 Suppl 1():S40-4. PubMed ID: 23700054
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Intrathecal chemotherapy in acute lymphoblastic leukemia. Prospective evaluation of toxicity using a combination employed in Mexico].
    Gómez-Almaguer D; Almaguer-Gaona C; Mora-Brondo P; González-Llano O; Marfil-Rivera J; Villarreal G
    Rev Invest Clin; 1988; 40(2):129-33. PubMed ID: 3175366
    [No Abstract]   [Full Text] [Related]  

  • 19. Symptomatic hypoglycemia in children receiving oral purine analogues for treatment of childhood acute lymphoblastic leukemia.
    Ziino O; Russo D; Orlando MA; Benigno V; Locatelli F; Aricò M
    Med Pediatr Oncol; 2002 Jul; 39(1):32-4. PubMed ID: 12116076
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Acral erythema with bullous formation: a side effect of chemotherapy in a child with acute lymphoblastic leukemia.
    Aytaç S; Gümrük F; Cetin M; Tuncer M; Yetgin S
    Turk J Pediatr; 2010; 52(2):211-4. PubMed ID: 20560263
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.